<?xml version="1.0" encoding="UTF-8"?>
<p>Convalescent plasma therapy relies on the administration of plasma from recovered COVID-19 patients. Previous coronavirus outbreaks including SARS-CoV and MERS-CoV as well as Ebola virus disease, avian influenza A (H5N1), 2009 H1N1 pandemic influenza A, respiratory syncytial virus, Zika viruses, human cytomegalovirus and rabies have confirmed the presence of neutralizing antibodies in convalescent serum [
 <xref rid="B173-ijms-21-05559" ref-type="bibr">173</xref>,
 <xref rid="B174-ijms-21-05559" ref-type="bibr">174</xref>]. However, convalescent plasma was not successful for Ebola [
 <xref rid="B175-ijms-21-05559" ref-type="bibr">175</xref>].
</p>
